Back to Insights

Continuation Breakout Monday 1PM 11/24/2025

November 24, 2025 5 min read

Overall Sector and Industry Analysis (EST range covered)
– Data analyzed covers 2025-11-24 from 10:00 to 13:00 EST (30-minute bars). Only today’s intraday snapshots were provided; I could not compute full 30-day/10-day studies. The commentary and levels below leverage today’s developing daily candle plus intraday structure.
– Healthcare/Biotech showed the broadest accumulation and momentum: NUVB, DNTH, MBX, GOSS, ANNX pushed higher through late morning; larger-cap biotech lagged or faded (VRTX drifted lower; JAZZ cooled after an early pop). This suggests a rotation into higher-beta/smaller-cap biotech within the healthcare complex.
– Consumer showed constructive tone: AS (discretionary) ground higher toward session highs; BRBR (staples/packaged foods) reclaimed and held highs with steady bids.
– Healthcare services also bid: BKD stair-stepped with rising 30-min volume into midday.
– Notable intraday patterns:
– Multiple names pressing or consolidating just beneath obvious round or session-high “gates” (NUVB near 7.50; DNTH near 44.20/45; RIGL testing the 50 handle; BRBR at new HOD 30.36). These “gate” levels often trigger 1-2 day continuation if reclaimed and held on a retest.
– Accumulation signatures: expanding volume on up-legs (NUVB, DNTH, MBX), controlled pullbacks to higher lows (AS, BRBR), and HOD closes/holds (MBX, BRBR).

Ticker Performance Prediction (next 2–3 days)
– Most likely to advance: NUVB, MBX, DNTH, BRBR, AS, BKD.
– Strongest bullish signals:
– MBX: Range expansion day, HOD hold, multiple higher highs and well-supported higher lows.
– NUVB: Stair-step advance with rising 30-min volume; holding near day highs.
– DNTH: Clean trend up, consolidating under resistance with shallow pullbacks.
– BRBR: HOD hold with steady bids; shallow dip-buys intraday.
– AS and BKD: Constructive grind-ups, demand visible on pullbacks.

Individual Stock Analysis (levels, plan, and targets)
Note on targets: Without 30-day ATRs, I use a conservative proxy based on today’s realized range (session high–low) as a near-term movement guide.

1) NUVB
– Supports (daily near-term zones from today’s candle):
– 7.37–7.40
– 7.32
– 7.22
– Resistances:
– 7.48–7.50 (session high area)
– 7.60
– 7.75–7.80 (range-extension zone)
– 30-min outlook (next 2–3 days): Prefer a pullback hold above 7.32–7.40, then a squeeze through 7.50. If 7.50 reclaims and holds on a 30-min retest, momentum extension toward 7.60 first, then 7.75–7.80 within 1–3 days.
– 1–3 day swing targets (proxy ATR ≈ 0.30):
– PT1: 7.48–7.50
– PT2: 7.60
– PT3: 7.75–7.80
– Entry ideas: 7.37–7.40 pullback, or 7.50 break-and-retest.
– Stop: 7.21–7.23 (below demand and morning pivot).
finviz dynamic chart for  NUVB

2) MBX
– Supports:
– 31.00–31.10 (round-number shelf)
– 30.66–30.70
– 30.28–30.35
– Resistances:
– 31.55 (HOD)
– 32.20–32.30
– 33.00–33.30 (range extension)
– 30-min outlook: Holding above 31 keeps control with a quick retest of 31.55. A decisive push/hold over 31.55 opens 32.2x, then 33.0x over 1–3 days.
– 1–3 day swing targets (proxy ATR ≈ 1.77):
– PT1: 31.55
– PT2: 32.20–32.30
– PT3: 33.00–33.30
– Entry ideas: 31.05–31.15 pullback hold; or 31.55 break-and-retest.
– Stop: 30.60 (beneath the 30.66 pivot) or tighter 30.85 if using a breakout add.
finviz dynamic chart for  MBX

3) DNTH
– Supports:
– 43.45–43.55
– 43.20–43.25
– 42.80–42.95
– Resistances:
– 43.90–44.00
– 44.21 (HOD)
– 45.00 (round number supply)
– 30-min outlook: Expect a base between 43.20–43.70, then a push into 43.90–44.21. A hold above 44.21 sets up a 1–2 day probe of 45.00.
– 1–3 day swing targets (proxy ATR ≈ 1.78):
– PT1: 43.90–44.00
– PT2: 44.50
– PT3: 45.00–45.20
– Entry ideas: 43.20–43.40 pullback; or 44.00–44.20 break-and-retest.
– Stop: 42.88 (beneath mid-morning shelf) or 42.40 if giving it more room.
finviz dynamic chart for  DNTH

4) BRBR
– Supports:
– 30.20–30.24
– 30.00
– 29.83 (session low)
– Resistances:
– 30.36 (HOD)
– 30.80–30.90
– 31.00–31.10
– 30-min outlook: Expect a tight bull flag above 30.10–30.20, then a push through 30.36. Sustained trade over 30.36 targets 30.8x, then a round-number test at 31.
– 1–3 day swing targets (proxy ATR ≈ 0.53):
– PT1: 30.36–30.40
– PT2: 30.80–30.90
– PT3: 31.00–31.10
– Entry ideas: 30.10–30.20 pullback; or 30.36 break-and-retest.
– Stop: 29.78–29.82 (beneath session low).
finviz dynamic chart for  BRBR

5) AS
– Supports:
– 35.69–35.72
– 35.50–35.55
– 35.39–35.44
– Resistances:
– 35.86 (session high)
– 36.10
– 36.50
– 30-min outlook: A grind-up continues if 35.55–35.72 holds. Over 35.86, look for 36.10 first; a 30-min hold above 36.10 opens a 36.3x–36.5x test within 1–3 days.
– 1–3 day swing targets (proxy ATR ≈ 0.47):
– PT1: 35.86
– PT2: 36.10–36.30
– PT3: 36.50–36.60
– Entry ideas: 35.55–35.65 pullback; or 35.90 break-and-retest.
– Stop: 35.35 (beneath morning demand).
finviz dynamic chart for  AS

6) BKD
– Supports:
– 11.10–11.15
– 11.00–11.02
– 10.95
– Resistances:
– 11.19–11.20 (session high)
– 11.30–11.35
– 11.50–11.55
– 30-min outlook: As long as price holds above 11.00–11.10, a retest of 11.19–11.20 is likely. A clean reclaim/hold above 11.20 can push to 11.35 first, then 11.50 into day 2–3.
– 1–3 day swing targets (proxy ATR ≈ 0.25):
– PT1: 11.19–11.20
– PT2: 11.30–11.35
– PT3: 11.50–11.55
– Entry ideas: 11.05–11.12 pullback; or 11.20 break-and-retest.
– Stop: 10.93–10.95 (beneath morning low/zone).
finviz dynamic chart for  BKD

Additional watchlist notes
– GOSS: Constructive higher highs; watch 3.20–3.23 for a clean break. Supports 3.13/3.08; stops below 3.05; targets 3.30 then 3.45 on follow-through.
– RIGL: Testing the 50 level is significant; a 30-min hold above 50 could quickly unlock 51–52; failure keeps it range-bound 48.8–49.8.
– Large-cap biotech check: VRTX fading intraday while small/mid-cap peers bid supports the rotation thesis; confirm with tomorrow’s relative strength before sizing up swing risk.

If you can provide the last 30 trading days (preferably daily plus 30-min bars), I’ll refine levels with proper multi-day supply/demand zones and compute true ATR-based targets.

Share: